首页 正文

An updated patent review of histone deacetylase (HDAC) inhibitors in cancer (2020 - present)

{{output}}
Introduction: Histone deacetylase (HDAC) inhibitors have been considered as an attractive strategy to reverse aberrant epigenetic changes associated with cancer treatments. The use of HDAC inhibitors in various cancer types has c... ...